Birdwatch Note
2023-07-22 13:20:32 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
動画にて語っている医師はアメリカの循環器系の専門医 Peter Mccullough氏です。 同氏はたびたびコロナワクチンに関する誤情報を拡散しており十分な注意が必要です https://t.co/HvPTVzW4tG コロナワクチンに関する提言が日本感染症学会よりリリースされています https://www.kansensho.or.jp/modules/guidelines/index.php?content_id=43 第4版にてリスクとメリットについて共に提言がなされております https://www.kansensho.or.jp/uploads/files/guidelines/2112_covid-19_4.pdf ギランバレー症候群はJ&JやAZのワクチンでプラセボ群に対してリスクが上がるとしていますが、日本国内では現在使用されていません 気になる場合はかかりつけ医もしくは専門医へご相談ください
Written by 8C44BC96921239E2A14AAFE89DBC27D0FCF6DF4DBA0CA8CE63A2F475BE527858
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1682220598423093249
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1682742424693780480
- noteId - 1682742424693780480
- participantId -
- noteAuthorParticipantId - 8C44BC96921239E2A14AAFE89DBC27D0FCF6DF4DBA0CA8CE63A2F475BE527858 Participant Details
- createdAtMillis - 1690032032548
- tweetId - 1682220598423093249
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- 動画にて語っている医師はアメリカの循環器系の専門医 Peter Mccullough氏です。 同氏はたびたびコロナワクチンに関する誤情報を拡散しており十分な注意が必要です https://t.co/HvPTVzW4tG コロナワクチンに関する提言が日本感染症学会よりリリースされています https://www.kansensho.or.jp/modules/guidelines/index.php?content_id=43 第4版にてリスクとメリットについて共に提言がなされております https://www.kansensho.or.jp/uploads/files/guidelines/2112_covid-19_4.pdf ギランバレー症候群はJ&JやAZのワクチンでプラセボ群に対してリスクが上がるとしていますが、日本国内では現在使用されていません 気になる場合はかかりつけ医もしくは専門医へご相談ください
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2023-07-22 13:20:32 UTC (1690032032548) |
2023-07-22 21:10:29 UTC (1690060229954) |
CURRENTLY_RATED_HELPFUL | 2023-07-23 04:10:19 UTC (1690085419289) |
NEEDS_MORE_RATINGS | 2023-07-22 21:10:29 UTC (1690060229954) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
rated at | rated by | |
2023-07-22 19:24:05 -0500 | Rating Details | |
2023-07-22 19:14:19 -0500 | Rating Details | |
2023-07-22 19:11:52 -0500 | Rating Details | |
2023-07-22 19:09:51 -0500 | Rating Details | |
2023-07-22 19:07:59 -0500 | Rating Details | |
2023-07-22 19:02:28 -0500 | Rating Details | |
2023-07-22 19:01:29 -0500 | Rating Details | |
2023-07-22 18:58:45 -0500 | Rating Details | |
2023-07-22 18:58:12 -0500 | Rating Details | |
2023-07-22 18:58:12 -0500 | Rating Details | |
2023-07-22 18:55:06 -0500 | Rating Details | |
2023-07-22 18:47:07 -0500 | Rating Details | |
2023-07-22 18:46:58 -0500 | Rating Details | |
2023-07-22 18:46:42 -0500 | Rating Details | |
2023-07-22 18:43:12 -0500 | Rating Details | |
2023-07-22 18:42:36 -0500 | Rating Details | |
2023-07-22 18:42:07 -0500 | Rating Details | |
2023-07-22 18:41:58 -0500 | Rating Details | |
2023-07-22 18:38:11 -0500 | Rating Details | |
2023-07-22 18:37:24 -0500 | Rating Details | |
2023-07-22 18:35:31 -0500 | Rating Details | |
2023-07-22 18:34:05 -0500 | Rating Details | |
2023-07-22 18:33:42 -0500 | Rating Details | |
2023-07-22 18:33:04 -0500 | Rating Details | |
2023-07-22 18:31:32 -0500 | Rating Details | |
2023-07-22 18:30:14 -0500 | Rating Details | |
2023-07-22 18:30:03 -0500 | Rating Details | |
2023-07-22 18:29:17 -0500 | Rating Details | |
2023-07-22 18:28:08 -0500 | Rating Details | |
2023-07-22 18:25:54 -0500 | Rating Details | |
2023-07-22 18:23:31 -0500 | Rating Details | |
2023-07-22 18:22:01 -0500 | Rating Details | |
2023-07-22 18:21:52 -0500 | Rating Details | |
2023-07-22 18:20:11 -0500 | Rating Details | |
2023-07-22 18:19:37 -0500 | Rating Details | |
2023-07-22 18:18:58 -0500 | Rating Details | |
2023-07-22 18:18:02 -0500 | Rating Details | |
2023-07-22 18:13:33 -0500 | Rating Details | |
2023-07-22 18:12:49 -0500 | Rating Details | |
2023-07-22 18:03:17 -0500 | Rating Details | |
2023-07-22 17:55:46 -0500 | Rating Details | |
2023-07-22 13:59:39 -0500 | Rating Details | |
2023-07-22 12:00:18 -0500 | Rating Details | |
2023-07-22 11:16:10 -0500 | Rating Details | |
2023-07-22 10:57:13 -0500 | Rating Details | |
2023-07-22 10:36:50 -0500 | Rating Details | |
2023-07-22 10:33:21 -0500 | Rating Details | |
2023-07-22 10:21:36 -0500 | Rating Details | |
2023-07-22 10:08:23 -0500 | Rating Details | |
2023-07-22 10:05:50 -0500 | Rating Details | |
2023-07-22 10:02:34 -0500 | Rating Details | |
2023-07-22 10:02:15 -0500 | Rating Details | |
2023-07-22 09:56:53 -0500 | Rating Details | |
2023-07-22 09:55:01 -0500 | Rating Details | |
2023-07-22 09:47:07 -0500 | Rating Details | |
2023-07-22 09:46:53 -0500 | Rating Details | |
2023-07-22 09:40:36 -0500 | Rating Details | |
2023-07-22 09:11:39 -0500 | Rating Details | |
2023-07-22 09:07:12 -0500 | Rating Details | |
2023-07-22 09:03:02 -0500 | Rating Details | |
2023-07-22 08:50:26 -0500 | Rating Details | |
2023-07-22 08:49:28 -0500 | Rating Details | |
2023-07-22 08:45:56 -0500 | Rating Details | |
2023-07-22 08:42:09 -0500 | Rating Details | |
2023-07-22 08:36:36 -0500 | Rating Details | |
2023-07-22 08:36:14 -0500 | Rating Details | |
2023-07-22 08:33:28 -0500 | Rating Details | |
2023-07-22 08:33:20 -0500 | Rating Details | |
2023-07-22 08:29:39 -0500 | Rating Details | |
2023-07-22 08:26:47 -0500 | Rating Details | |
2023-07-22 08:26:10 -0500 | Rating Details | |
2023-07-22 20:12:40 -0500 | Rating Details | |
2023-07-22 20:08:40 -0500 | Rating Details | |
2023-07-22 20:06:52 -0500 | Rating Details | |
2023-07-22 20:01:56 -0500 | Rating Details | |
2023-07-22 19:59:28 -0500 | Rating Details | |
2023-07-22 19:53:40 -0500 | Rating Details | |
2023-07-22 19:53:26 -0500 | Rating Details | |
2023-07-22 19:49:26 -0500 | Rating Details | |
2023-07-22 19:38:01 -0500 | Rating Details | |
2023-07-22 19:37:25 -0500 | Rating Details | |
2023-07-22 19:36:12 -0500 | Rating Details | |
2023-07-22 19:35:28 -0500 | Rating Details | |
2023-07-22 11:58:49 -0500 | Rating Details | |
2023-07-24 17:17:19 -0500 | Rating Details | |
2023-07-24 15:49:29 -0500 | Rating Details | |
2023-07-24 15:03:36 -0500 | Rating Details | |
2023-07-22 19:13:40 -0500 | Rating Details | |
2023-07-22 18:26:44 -0500 | Rating Details | |
2023-07-25 07:47:39 -0500 | Rating Details | |
2023-07-24 20:46:48 -0500 | Rating Details | |
2023-07-26 03:08:14 -0500 | Rating Details | |
2023-07-24 16:06:00 -0500 | Rating Details | |
2023-07-22 20:10:51 -0500 | Rating Details | |
2023-07-22 20:09:05 -0500 | Rating Details | |
2023-07-22 20:08:44 -0500 | Rating Details | |
2023-07-22 19:40:08 -0500 | Rating Details | |
2023-07-22 19:38:14 -0500 | Rating Details | |
2023-07-22 19:25:15 -0500 | Rating Details | |
2023-07-22 19:03:25 -0500 | Rating Details | |
2023-07-22 18:57:40 -0500 | Rating Details | |
2023-07-22 18:32:32 -0500 | Rating Details | |
2023-07-22 19:38:07 -0500 | Rating Details | |
2023-07-22 19:09:07 -0500 | Rating Details | |
2023-07-22 18:22:04 -0500 | Rating Details | |
2023-07-22 18:19:33 -0500 | Rating Details | |
2023-07-22 18:03:04 -0500 | Rating Details | |
2023-07-24 20:25:07 -0500 | Rating Details | |
2023-07-22 19:21:13 -0500 | Rating Details | |
2023-07-22 19:02:52 -0500 | Rating Details | |
2023-07-22 18:37:39 -0500 | Rating Details | |
2023-07-25 03:49:43 -0500 | Rating Details | |
2023-08-03 16:49:04 -0500 | Rating Details | |
2023-08-03 08:20:54 -0500 | Rating Details | |
2023-08-03 22:53:02 -0500 | Rating Details | |
2023-08-05 00:56:40 -0500 | Rating Details |